New scan could spot cancer marker better than current tests
NCT ID NCT06369831
First seen Jun 04, 2026
Summary
This study tests a new type of PET/CT scan that uses a radioactive tracer called 68Ga-ABS011 to detect HER2, a protein found on some cancer cells. The goal is to see if this scan can more accurately determine HER2 status in people with metastatic breast cancer or other solid tumors that have spread. Researchers will compare the scan results with standard biopsy and imaging methods. The study involves 60 adults and aims to improve how doctors choose the right treatments for each patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ Delta CHIREC
RECRUITINGBrussels, Brussels Capital, 1070, Belgium
Contact
Contact
-
Cliniques Universitaires Saint-Luc
RECRUITINGBrussels, Brussels Capital, 1070, Belgium
Contact
-
Free University Brussels (VUB)
RECRUITINGBrussels, Brussels Capital, 1070, Belgium
Contact
-
Institut Jules Bordet
RECRUITINGBrussels, Brussels Capital, 1070, Belgium
Contact
-
Medizinische Universität Innsbruck
RECRUITINGInnsbruck, Tyrol, A-6020, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
OLV Aalst
COMPLETEDAalst, East-Flanders, 9300, Belgium
-
University Hospital Gasthuisberg
RECRUITINGLeuven, Belgium
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.